DNA scan yields insights into Germany's E. coli bug

Jun 23, 2011

A strain of E. coli bacteria blamed for killing dozens of people in Germany is a genetic mix whose ability to stick to intestinal walls may have made it so lethal, a study in The Lancet said on Wednesday.

A team led by Helge Karch, a professor at the University of Muenster, said the germ O104:H4 was a rare kind that in essence was a "clone" of a strain first detected in a young patient in Germany in 2001.

Its genes for virulence come from two strains that have combined, they said.

One strain, called enterohaemorragic E. coli (EHEC), releases poisons called Shiga toxins.

The other, called enteroaggregative E. coli (EAEC), adheres in a "stacked brick" fashion to epithelial cells which constitute the intestinal lining.

Sequencing by gene labs in the United States and China last month also spoke of a hybrid EHEC-EAEC strain.

The new study, delving into a catalogue of bacteria, said the mix had been around, albeit in a rare form, for a decade.

What is different from the 2001 germ, it added, are genes that make it resistant to members of a broad class of antibiotics called beta-lactams.

The germ was resistant to all penicillins and cephalosporins, but susceptible to carbapenems.

This blending of traits could explain the exceptional virulence of the strain and suggests beta-lactams may have inadvertently made things worse by wiping out rivals to the , says the study.

Nearly a quarter of those infected in the outbreak have developed haemolytic uraemic syndrome (HUS), which includes kidney impairment, a breakdown of and lack of blood-clotting components called platelets.

"The enhanced adherence of this strain to intestinal epithelial cells might facilitate systemic absorption of Shiga toxin and could explain the of progression to HUS," the study suggested.

" might also play a part if beta-lactam drugs used to treat the infection suppressed competing microbiota."

As of June 20, there had been 39 recorded deaths, 810 cases of HUS and 2,684 non-HUS cases, entailing bloody diarrhoea, the paper said.

By comparison, most people with just EHEC infection recover completely, and usually fewer than 10 percent of them develop serious complications, including HUS.

Karch's team analysed the DNA from stool samples found in 80 patients with HUS that were submitted to the lab in Muenster between May 23 and June 2.

All of these samples were "clones," or copies, of the HUSEC041, an E. coli strain identified in 2001 in a child with HUS.

Explore further: US official warns Ebola outbreak will get worse

add to favorites email to friend print save as pdf

Related Stories

Suspected deadly E. coli outbreak in Germany

May 24, 2011

German authorities reported Tuesday three suspected deaths from a strain of the E. coli bacterium and warned more were likely because of a "scarily high" number of new infections.

Germany 'really worried' by E. coli outbreak

May 25, 2011

Germany's consumer minister expressed deep concern Wednesday at an outbreak of poisoning by dangerous bacteria believed to have killed three women and left hundreds ill.

Recommended for you

US official warns Ebola outbreak will get worse

22 minutes ago

A third top doctor has died from Ebola in Sierra Leone, a government official said Wednesday, as a leading American health official warned that the outbreak sweeping West Africa would get worse before it ...

UN releases $1.5mn to help DR Congo fight Ebola

2 hours ago

The United Nations on Wednesday allocated $1.5 million (1.1 million euros) to help the Democratic Republic of Congo fight Ebola, just days after the country confirmed its first cases this year.

'Junk' blood tests may offer life-saving information

3 hours ago

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated"—they reflect the presence of skin germs instead of specific disease-causing bacteria.

Drug represents first potential treatment for common anemia

4 hours ago

An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society o ...

User comments : 0